(1)
PARMAR VINENDRA M; GOSWAMI SUNITA S. EFFICACY AND SAFETY OF TENELIGLIPTIN AS ADD-ON THERAPY TO CONVENTIONAL THERAPY IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Asian J Pharm Clin Res 2019, 12, 116-120.